First experience with (224)Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study).

Larsen SG, Graf W, Mariathasan AB, Sørensen O, Spasojevic M, Goscinski MA, Selboe S, Lundstrøm N, Holtermann A, Revheim ME, Bruland ØS

Open source

DOI: 10.3389/fmed.2023.1070362
Published: 2023
Container: Frontiers in medicine
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2023.1070362,
  title = {First experience with (224)Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study).},
  author = {Larsen SG and Graf W and Mariathasan AB and Sørensen O and Spasojevic M and Goscinski MA and Selboe S and Lundstrøm N and Holtermann A and Revheim ME and Bruland ØS},
  year = {2023},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2023.1070362},
  url = {https://doi.org/10.3389/fmed.2023.1070362}
}

RIS

TY  - JOUR
TI  - First experience with (224)Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study).
AU  - Larsen SG
AU  - Graf W
AU  - Mariathasan AB
AU  - Sørensen O
AU  - Spasojevic M
AU  - Goscinski MA
AU  - Selboe S
AU  - Lundstrøm N
AU  - Holtermann A
AU  - Revheim ME
AU  - Bruland ØS
PY  - 2023
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2023.1070362
UR  - https://doi.org/10.3389/fmed.2023.1070362
ER  -

APA

SG, L., W, G., AB, M., O, S., M, S., MA, G., S, S., N, L., A, H., ME, R., & ØS, B. (2023). First experience with (224)Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study).. Frontiers in medicine. https://doi.org/10.3389/fmed.2023.1070362

Source records

pubmed · retrieved 2026-09-26T08:35:23.855Z
europe-pmc · retrieved 2026-09-26T08:35:23.870Z
doaj · retrieved 2026-09-26T08:35:23.848Z